The SeptiCyteTM LAB may be an effective complementary diagnostic tool to clinical assessment of critically ill adult patients in discriminating between sepsis and noninfectious systemic inflammation syndrome.
Low-dose computed tomography may assist clinicians in modifying diagnosis of elderly patients who are admitted with suspected pneumonia.
A childhood measles infection may increase the risk for post-bronchodilator airflow obstruction in middle-age adults via its interaction with asthma and smoking.
Large cavitary lung disease may increase cough frequency that lasts for a longer duration in individuals with tuberculosis.
The risk for death in patients with community-acquired pneumonia who were given mechanical ventilation does not seem to be affected by the presence of acute respiratory distress syndrome.
Differences in serum inflammatory markers may exist between patients with community-acquired pneumonia who present within the first 48 hours of symptom onset vs those who present later.
In an attempt to determine if the presence of S aureus could be used as a marker for more severe disease, investigators assessed the relationship between S aureus-positive bronchiectasis infection and pulmonary function, frequency of exacerbations, and hospital admissions.
The utilization of this tool could prevent severe complications secondary to delayed pneumonia diagnosis and treatment.
Patients admitted to hospitals with severe CAP who subsequently required invasive mechanical ventilation had a higher mortality risk.
Patients with type 2 diabetes treated with sulfonylureas may be at a higher risk of contracting tuberculosis.
